Quarry Thera
The Future of Induced Proximity Therapeutics
United States · Founded 2023 · $32.0M raised
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- quarrythera.com
- Total Funding
- $32.0M
- Last Round
- $32.0M Series ANov 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Quarry Thera advances induced-proximity therapeutics through drug-like molecules that stabilize novel protein–protein interactions and heterobifunctional small molecules engineered to drive targeted biological outcomes. Its scientists bring experience advancing the field and delivering medicines into a new generation of chemistry. Chief Scientific Officer Jeanne Magram leads scientific strategy and advancement of the company’s proximity-induced therapeutics platform.
Summary
Quarry Thera is a Biotech company based in United States, founded in 2023. It has raised $32.0M in total across 1 round, most recently a $32.0M Series A round in Nov 2025. Investors include Yosemite, Canaan Partners and F-Prime Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/quarry-thera"><img src="https://indexed.vc/api/badge/company/quarry-thera" alt="Quarry Thera on Indexed.vc" width="260" height="76" /></a>